DE69410118D1 - CYCLODEXTRINDERIVATE ZUR AUFLöSUNG VON HYDROPHOBEN, CHEMISCHEN VERBINDUNGEN WIE ARZNEIMITTELN; VERFAHREN ZU DEREN HERSTELLUNG - Google Patents

CYCLODEXTRINDERIVATE ZUR AUFLöSUNG VON HYDROPHOBEN, CHEMISCHEN VERBINDUNGEN WIE ARZNEIMITTELN; VERFAHREN ZU DEREN HERSTELLUNG

Info

Publication number
DE69410118D1
DE69410118D1 DE69410118T DE69410118T DE69410118D1 DE 69410118 D1 DE69410118 D1 DE 69410118D1 DE 69410118 T DE69410118 T DE 69410118T DE 69410118 T DE69410118 T DE 69410118T DE 69410118 D1 DE69410118 D1 DE 69410118D1
Authority
DE
Germany
Prior art keywords
hydrophobic
resolution
production
chemical compounds
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69410118T
Other languages
English (en)
Other versions
DE69410118T2 (de
Inventor
Florence Djedaini-Pilard
Nathalie Azaroual-Bellanger
Bruno Perly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Publication of DE69410118D1 publication Critical patent/DE69410118D1/de
Application granted granted Critical
Publication of DE69410118T2 publication Critical patent/DE69410118T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69410118T 1993-12-22 1994-12-21 CYCLODEXTRINDERIVATE ZUR AUFLöSUNG VON HYDROPHOBEN, CHEMISCHEN VERBINDUNGEN WIE ARZNEIMITTELN; VERFAHREN ZU DEREN HERSTELLUNG Expired - Lifetime DE69410118T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9315472A FR2714067B1 (fr) 1993-12-22 1993-12-22 Nouveaux dérivés de cyclodextrines, utilisables en particulier pour solubiliser des composés chimiques hydrophobes tels que des médicaments, et leur procédé de préparation.
PCT/FR1994/001501 WO1995017432A1 (fr) 1993-12-22 1994-12-21 Derives de cyclodextrine, utilisables pour solubiliser des composes chimiques hydrophobes tels que des medicaments, et leurs procedes de preparation

Publications (2)

Publication Number Publication Date
DE69410118D1 true DE69410118D1 (de) 1998-06-10
DE69410118T2 DE69410118T2 (de) 1998-11-12

Family

ID=9454244

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69410118T Expired - Lifetime DE69410118T2 (de) 1993-12-22 1994-12-21 CYCLODEXTRINDERIVATE ZUR AUFLöSUNG VON HYDROPHOBEN, CHEMISCHEN VERBINDUNGEN WIE ARZNEIMITTELN; VERFAHREN ZU DEREN HERSTELLUNG

Country Status (8)

Country Link
US (1) US5760017A (de)
EP (1) EP0736044B1 (de)
JP (1) JP3509866B2 (de)
AU (1) AU688440B2 (de)
DE (1) DE69410118T2 (de)
FR (1) FR2714067B1 (de)
HU (1) HU219605B (de)
WO (1) WO1995017432A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3865436B2 (ja) * 1996-07-11 2007-01-10 塩水港精糖株式会社 分岐シクロデキストリンの製造方法
JP2002523475A (ja) * 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
US6527887B1 (en) 2002-01-18 2003-03-04 Mach I, Inc. Polymeric cyclodextrin nitrate esters
DE10344967B4 (de) * 2003-09-07 2011-07-28 Henkel AG & Co. KGaA, 40589 Alkoxylgruppen-haltige Cyclodextrin-Derivate; Verfahren zu deren Herstellung und deren Verwendung
US20080234182A1 (en) * 2007-03-22 2008-09-25 Innovative Biologics, Inc. Blockers of pore-forming virulence factors and their use as anti-infectives
US7851457B2 (en) * 2004-01-29 2010-12-14 Innovative Biologics, Inc. β-Cyclodextrin derivatives
US20050234018A1 (en) * 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
CA2596026A1 (en) * 2005-01-28 2006-08-10 Pinnacle Pharmaceuticals, Inc. .beta.-cyclodextrin derivatives as antibacterial agents
US20070238789A1 (en) * 2006-03-31 2007-10-11 Chin-Ming Chang Prednisolone acetate compositions
DK2023896T3 (en) * 2006-05-19 2016-10-03 Viroblock Sa A composition for the inactivation of enveloped viruses
EP2167546A1 (de) * 2007-07-11 2010-03-31 Ophthalmopharma AG Komplexe von prostaglandinderivaten und einfach substituierte, geladene beta-cyclodextrine
FR2923391B1 (fr) * 2007-11-08 2012-07-27 Biocydex Compositions pour conserver des cellules, des tissus ou des organes, procede d'obtention et utilisations.
US20110229544A1 (en) * 2008-11-26 2011-09-22 Viroblock S.A. Methods for Inhibiting Gram-Postive Bacteria Using Non-Phospholipid Lipid Vesicules
JP5364923B2 (ja) * 2009-01-28 2013-12-11 学校法人福岡大学 多機能性シクロデキストリン誘導体、その包接化合物およびそれらの製造方法。
FR2942622B1 (fr) 2009-02-27 2011-05-13 Commissariat Energie Atomique Procede de preparation de particules de silice poreuses, lesdites particules et leurs utilisations
WO2014058438A1 (en) * 2012-10-12 2014-04-17 Empire Technology Development Llc Paints and coatings containing cyclodextrin additives
CN105175580A (zh) * 2015-10-14 2015-12-23 中山大学 一种基于氨基酸还原物氨基醇β-环糊精衍生物及其制备方法与应用
CA3183207A1 (en) 2020-06-18 2021-12-23 Daniel Joseph Fitzgerald Fatty acid complexes of coronavirus spike protein and their use
EP4243805A1 (de) 2020-08-07 2023-09-20 Gbiotech S.À.R.L. Kombinationstherapien zur behandlung von coronavirusinfektion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62123196A (ja) * 1985-11-22 1987-06-04 Nisshin Flour Milling Co Ltd プレドニゾロン包接化合物
EP0518930A4 (en) * 1990-03-02 1993-09-15 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications

Also Published As

Publication number Publication date
US5760017A (en) 1998-06-02
EP0736044A1 (de) 1996-10-09
EP0736044B1 (de) 1998-05-06
FR2714067A1 (fr) 1995-06-23
JP3509866B2 (ja) 2004-03-22
HUT74941A (en) 1997-03-28
AU688440B2 (en) 1998-03-12
HU219605B (hu) 2001-05-28
HU9601736D0 (en) 1996-08-28
DE69410118T2 (de) 1998-11-12
FR2714067B1 (fr) 1996-01-12
AU1319895A (en) 1995-07-10
JPH09507086A (ja) 1997-07-15
WO1995017432A1 (fr) 1995-06-29

Similar Documents

Publication Publication Date Title
DE69410118T2 (de) CYCLODEXTRINDERIVATE ZUR AUFLöSUNG VON HYDROPHOBEN, CHEMISCHEN VERBINDUNGEN WIE ARZNEIMITTELN; VERFAHREN ZU DEREN HERSTELLUNG
ATE222251T1 (de) Substituierte heterocyclische verbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE69201775D1 (de) Innenrippe und Verfahren zu deren Herstellung.
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE266005T1 (de) Arylsubstituierte propanolaminderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE59908522D1 (de) Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE3863366D1 (de) Antibiotikum vermisporin, verfahren zu dessen herstellung und dasselbe als aktiver antibakterieller wirkstoff enthaltende pharmazeutische zusammensetzung.
ATE150033T1 (de) N,o-sulfatierte heparosane; verfahren zu deren herstellung und diese enthaltende arzneimittel
DE69602255D1 (de) Lenksäulenverriegelung und verfahren zu deren herstellung
DE3780532D1 (de) Amphoterische staerke und verfahren zu deren herstellung.
DE3680877D1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3770982D1 (de) Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
DE3770956D1 (de) Flavonglycosid, verfahren zur herstellung und pharmazeutische zusammensetzung, welche dieses produkt enthaelt.
DE68923940D1 (de) Standardsubstanz zur optischen Kalibrierung und Verfahren zu deren Herstellung.
ATE177732T1 (de) Benzylsulfid-derivate, verfahren zu deren herstellung und diese enthaltende schädlingsbekämpfungsmittel
DE3881950D1 (de) Azabicyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69506431D1 (de) Stärkeprodukte als tablettierhilfstoff, verfahren zu deren herstellung und verfahren zur herstellung von tabletten
DE3862937D1 (de) 3-oxo-propannitril heteroarylderivate und verfahren zu deren herstellung.
DE3862019D1 (de) Homogene, mehrfarbig strukturierte kunststoffbahn oder -platte sowie verfahren zu deren herstellung.
DE68902670D1 (de) Ks-506 verbindungen und verfahren zu deren herstellung.
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68901039D1 (de) Indolylpiperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische verbindungen.
DE3877709D1 (de) Indan-derivate und verfahren zu deren herstellung.
AT397797B (de) Capsaicin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition